<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.GN updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.GN</link>
    <description>q-bio.GN updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.GN" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Wed, 10 Dec 2025 05:01:07 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Wed, 10 Dec 2025 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>needLR: Long-read structural variant annotation with population-scale frequency estimation</title>
      <link>https://arxiv.org/abs/2512.08175</link>
      <description>arXiv:2512.08175v1 Announce Type: new 
Abstract: Summary: We present needLR, a structural variant (SV) annotation tool that can be used for filtering and prioritization of candidate pathogenic SVs from long-read sequencing data using population allele frequencies, annotations for genomic context, and gene-phenotype associations. When using population data from 500 presumably healthy individuals to evaluate nine test cases with known pathogenic SVs, needLR assigned allele frequencies to over 97.5% of all detected SVs and reduced the average number of novel genic SVs to 121 per case while retaining all known pathogenic variants. Availability and Implementation: needLR is implemented in bash with dependencies including Truvari v4.2.2, BEDTools v2.31.1, and BCFtools v1.19. Source code, documentation, and pre-computed population allele frequency data are freely available at https://github.com/jgust1/needLR under an MIT license.</description>
      <guid isPermaLink="false">oai:arXiv.org:2512.08175v1</guid>
      <category>q-bio.GN</category>
      <pubDate>Wed, 10 Dec 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>new</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:creator>Jonas A. Gustafson, Jiadong Lin, Evan E. Eichler, Danny E. Miller</dc:creator>
    </item>
    <item>
      <title>ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials</title>
      <link>https://arxiv.org/abs/2512.08226</link>
      <description>arXiv:2512.08226v1 Announce Type: new 
Abstract: Personalized neoantigen vaccines represent a promising immunotherapy approach that harnesses tumor-specific antigens to stimulate anti-tumor immune responses. However, the design of these vaccines requires sophisticated computational workflows to predict and prioritize neoantigen candidates from patient sequencing data, coupled with rigorous review to ensure candidate quality. While numerous computational tools exist for neoantigen prediction, to our knowledge, there are no established protocols detailing the complete process from raw sequencing data through systematic candidate selection. Here, we present ImmunoNX (Immunogenomics Neoantigen eXplorer), an end-to-end protocol for neoantigen prediction and vaccine design that has supported over 185 patients across 11 clinical trials. The workflow integrates tumor DNA/RNA and matched normal DNA sequencing data through a computational pipeline built with Workflow Definition Language (WDL) and executed via Cromwell on Google Cloud Platform. ImmunoNX employs consensus-based variant calling, in-silico HLA typing, and pVACtools for neoantigen prediction. Additionally, we describe a two-stage immunogenomics review process with prioritization of neoantigen candidates, enabled by pVACview, followed by manual assessment of variants using the Integrative Genomics Viewer (IGV). This workflow enables vaccine design in under three months. We demonstrate the protocol using the HCC1395 breast cancer cell line dataset, identifying 78 high-confidence neoantigen candidates from 322 initial predictions. Although demonstrated here for vaccine development, this workflow can be adapted for diverse neoantigen therapies and experiments. Therefore, this protocol provides the research community with a reproducible, version-controlled framework for designing personalized neoantigen vaccines, supported by detailed documentation, example datasets, and open-source code.</description>
      <guid isPermaLink="false">oai:arXiv.org:2512.08226v1</guid>
      <category>q-bio.GN</category>
      <pubDate>Wed, 10 Dec 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>new</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Kartik Singhal, Evelyn Schmidt, Susanna Kiwala, S. Peter Goedegebuure, Christopher A. Miller, Huiming Xia, Kelsy C. Cotto, Jinglun Li, Jennie Yao, Luke Hendrickson, Miller M. Richters, My H. Hoang, Mariam Khanfar, Isabel Risch, Shelly O'Laughlin, Nancy Myers, Tammi Vickery, Sherri R. Davies, Feiyu Du, Thomas B. Mooney, Adam Coffman, Gue Su Chang, Jasreet Hundal, John E. Garza, Michael D. McLellan, Joshua F. McMichael, John Maruska, William Blake Inabinett, William A. Hoos, Rachel Karchin, Tanner M. Johanns, Gavin P. Dunn, Russel K. Pachynski, Todd A. Fehniger, Jeffrey P. Ward, Jennifer A. Foltz, William E. Gillanders, Obi L. Griffith, Malachi Griffith</dc:creator>
    </item>
    <item>
      <title>A Graph-based Approach to Variant Extraction from Sequences</title>
      <link>https://arxiv.org/abs/2503.18472</link>
      <description>arXiv:2503.18472v2 Announce Type: replace 
Abstract: Accurate variant descriptions are of paramount importance in the field of genomics. The domain is confronted with increasingly complex variants, e.g., combinations of multiple indels, making it challenging to generate proper variant descriptions directly from chromosomal sequences. We present a graph based on all minimal alignments that is a complete representation of a variant, which gives insight into the nature of a variant compared to a single variant description. We provide three complementary extraction methods to derive variant descriptions from this graph, including one that yields domain-specific constructs from the HGVS nomenclature. Our experiments show that our methods in comparison with dbSNP, the authoritative variant database from the NCBI, result in identical HGVS descriptions for simple variants and more meaningful descriptions for complex variants, in particular for repeat expansions and contractions.</description>
      <guid isPermaLink="false">oai:arXiv.org:2503.18472v2</guid>
      <category>q-bio.GN</category>
      <category>cs.DS</category>
      <pubDate>Wed, 10 Dec 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>replace</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <arxiv:DOI>10.1093/nargab/lqaf173</arxiv:DOI>
      <arxiv:journal_reference>NAR Genomics and Bioinformatics, Volume 7, Issue 4, December 2025</arxiv:journal_reference>
      <dc:creator>Mark A. Santcroos, Walter A. Kosters, Mihai Lefter, Jeroen F. J. Laros, Jonathan K. Vis</dc:creator>
    </item>
  </channel>
</rss>
